Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
128.7 USD | -0.09% | -1.56% | +18.03% |
05:02pm | Merck: encouraging results in gastric cancer | CF |
01/05 | Merck Says Keytruda Meets Primary Endpoint in Late-Stage Gastric Cancer Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.03% | 326B | |
+30.32% | 699B | |
+25.07% | 571B | |
-4.77% | 364B | |
+2.69% | 286B | |
+14.68% | 236B | |
+4.71% | 198B | |
-12.43% | 194B | |
-3.39% | 154B | |
-4.29% | 149B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Merck & Co. Plans $470 Million Investment In Manufacturing Facilities In Ireland